Fennec Pharmaceuticals Inc.

NASDAQ:FENC

Biotechnology

Healthcare
$13.33 -1.34%

-$0.12 today

Market cap
$470.62M
Beta
1.08
P/E (TTM)
-36.3
EPS (TTM)
-$0.24
52W Low $5.65High $10.45

Volume 0.59M

Average 0.26M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$12.47M

FY 2025 · Annual

Investing Cash Flow

$0.00

FY 2025 · Annual

Financing Cash Flow

$22.63M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(17.35M)(23.71M)(16.05M)(436K)(10.27M)
Depreciation & Amortization16K149K287K959K103K
Deferred Income Tax00000
Stock-Based Compensation4.01M4.22M5.35M5.06M7.03M
Change in Working Capital(138K)(509K)(8.17M)(7.33M)(15.09M)
Accounts Receivables0(1.55M)(7.27M)(7.87M)(12.66M)
Inventory0(576K)(1.58M)579K(1.3M)
Accounts Payables00001.42M
Other Working Capital(138K)1.61M683K(35K)(2.55M)
Other Non-Cash Items(769K)1.8M1.43M28.73M5.76M
Operating Cash Flow(14.22M)(18.06M)(17.14M)26.98M(12.47M)
Capital Expenditures00000
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow00000
Debt Repayment5M20.17M5M(13M)(19.82M)
Common Stock Issued33K00045.01M
Common Stock Repurchased0(194K)(78K)(176K)0
Dividends Paid00000
Other Financing Activities(55K)753K1.72M(439K)(2.57M)
Financing Cash Flow4.98M20.73M6.64M(13.62M)22.63M
Effect of Forex Changes00000
Net Change in Cash(9.24M)2.67M(10.51M)13.37M10.15M
Free Cash Flow(14.22M)(18.06M)(17.14M)26.98M(12.47M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$10.3M
+ D&A$103.0K
+ Stock-Based Comp$7.0M
+ Deferred Tax$0
- Working Capital-$15.1M
+ Other Non-Cash$5.8M
= Operating Cash Flow-$12.5M
- Capex$0
= Free Cash Flow-$12.5M

Analysis

FY2025 free cash flow is -$12.5M. FCF conversion is 121.4% of net income. Operating cash flow was -$12.5M, with capex of $0. The largest bridge item is Working Capital at -$15.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026

Does FENC generate free cash flow?

Fennec Pharmaceuticals Inc. (FENC) generated -$12.47M of free cash flow in fiscal 2025.

How much operating cash flow does FENC produce?

Operating cash flow was -$12.47M, before capital expenditures of $0.00.